单核苷酸多态性对中国HIV感染儿童依非韦伦和洛匹那韦/利托那韦血药浓度的影响
该研究在229例中国HIV感染儿童中检测CYP2B6、ABCB1和SLCO1B1基因多态性,并对39例和69例分别接受依非韦伦和洛匹那韦/利托那韦治疗的儿童进行血药浓度监测。发现CYP2B6 516G→T与依非韦伦浓度显著相关,年龄大于10岁者依非韦伦浓度更高,提示基因分型和浓度监测有助于优化儿童抗逆转录病毒治疗。
要点
- CYP2B6 516G→T与依非韦伦血药浓度显著相关,可指导剂量调整。
- 接受监测的儿童中21%依非韦伦浓度和39%洛匹那韦浓度超过治疗窗上限。
- 年龄大于10岁的儿童依非韦伦浓度显著高于低龄儿童。
核心结论
- CYP2B6 516G→T与依非韦伦浓度显著相关,基因分型和浓度监测可能有助于优化儿童依非韦伦方案。
研究设计与样本
- 研究纳入229例中国HIV感染儿童(年龄4.0至17.5岁)进行基因分型,并对39例接受依非韦伦和69例接受洛匹那韦/利托那韦治疗的儿童测定血浆药物浓度。
主要发现
- CYP2B6 516G→T基因型频率为G/G 71%、G/T 25%、T/T 4%。
- 接受治疗药物监测的儿童中,21%依非韦伦浓度和39%洛匹那韦浓度超过治疗窗上限。
- CYP2B6 516G→T与依非韦伦浓度显著相关(p<0.001)。
- 年龄大于10岁的儿童依非韦伦浓度显著高于 younger ones(p=0.0314)。
临床怎么用
- 对开始依非韦伦为基础方案的儿童,可考虑CYP2B6基因分型和依非韦伦浓度监测以优化治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Single nucleotide polymorphisms (SNPs) in the genes that encode the cytochrome P450 (CYP) drug metabolizing enzymes and drug transporters have been reported to influence antiretroviral drug pharmacokinetics. Although primarily metabolized by CYP2B6 and -3A, efavirenz (EFV) and lopinavir/ritonavir (LPV/r) are substrates of P-glycoprotein and the solute carrier organic (SLCO) anion transporter, respectively. We investigated the association between SNPs and efavirenz (EFV) or lopinavir/ritonavir (LPV/r) concentrations in Chinese children infected with the human immunodeficiency virus (HIV). Genotyping was performed on CYP2B6 516G→T, -1459C→T, and -983T→C, ABCB1 3435C→T, and SLCO1B1 521T→C in 229 HIV-infected Chinese pediatric patients (age range 4.0 to 17.5 yrs). Plasma concentrations of EFV and LPV/r were measured using validated high-performance liquid chromatography coupled with the mass spectrum method among 39 and 69 children who received EFV- and LPV/r-containing regimens, respectively. The frequencies of CYP2B6 516G→T in the study participants were 71%, 25%, and 4% for the G/G, G/T, and T/T genotypes, respectively. Among the children under therapeutic drug monitoring, 21% and 39% experienced EFV and LPV concentrations, respectively, above the upper threshold of the therapeutic window. CYP2B6 516G→T was significantly associated with EFV concentrations (p<0.001). Older children (older than 10 yrs) were more likely to have significantly higher EFV concentrations than the younger ones (p=0.0314). CYP2B6 genotyping and EFV concentration monitoring may help optimize antiretroviral therapy in pediatric patients who initiate an EFV-based regimen.
引用
- Liu X, Ma Q, Zhao Y, et al. Impact of Single Nucleotide Polymorphisms on Plasma Concentrations of Efavirenz and Lopinavir/Ritonavir in Chinese Children Infected with the Human Immunodeficiency Virus. Pharmacotherapy. 2017. PMID: 28718515. doi:10.1002/phar.1988
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。